Goldman Sachs’s Climb Bio CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$250K Buy
2025
Q1
$147K Sell
2024
Q4
$226K Buy
2024
Q3
$301K Buy
2022
Q3
Sell
2022
Q2
$492K Sell
2022
Q1
$1.39M Buy
2021
Q4
$1.72M Sell
2021
Q3
$2.98M Buy